Results 171 to 180 of about 1,140,223 (331)
The impact of the new WHO classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma. [PDF]
Degenhardt J+19 more
europepmc +1 more source
SIDE EFFECTS OF INTERFERON-α (INF-α) THERAPY FOR RENAL CELL CARCINOMA
Yoshihiro Totsuka+5 more
openalex +2 more sources
STK25 Loss Augments Anti‐PD‐1 Therapy Efficacy by Regulating PD‐L1 Stability in Colorectal Cancer
This study demonstrates that STK25 depletion facilitates CRC immune escape through the inhibition of PD‐L1 Ser283 phosphorylation‐mediated ubiquitination, and promotes tumor growth. Furthermore, these findings identify STK25 as a potential therapeutic target to trigger antitumor immunity and promote immunotherapy efficacy. Abstract Tumor immune evasion
Xiaowen Qiao+20 more
wiley +1 more source
EAU guidelines on renal cell carcinoma: 2014 update.
B. Ljungberg+14 more
semanticscholar +1 more source
Determinants of late metastases in renal cell carcinoma. [PDF]
Kapur P+16 more
europepmc +1 more source
The role of splicing factor 3A subunit 3 (SF3A3) in driving endometrial cancer (EC) progression and potential therapeutic interventions. SF3A3, a core component of the U2 small nuclear ribonucleoprotein (U2 snRNP), is upregulated in endometrial cancer (EC) and promotes tumor growth and cisplatin resistance. RNA‐binding protein immunoprecipitation (RIP)
Wei Yu+13 more
wiley +1 more source
Inducing ferroptosis is a promising strategy for combating tumor resistance. Upregulated PIP5K1A competes with NRF2 for KEAP1 binding, which decreases the ubiquitination degradation of NRF2 and promotes its nuclear translocation, thereby suppressing ferroptosis, and ultimately driving hepatocellular carcinoma (HCC) tumorigeneses and sorafenib ...
Mengzhou Guo+9 more
wiley +1 more source
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
E. Jonasch, C. Walker, W. Rathmell
semanticscholar +1 more source